Takeover

Acquirers

Menlo Therapeutics Inc.

Targets
1
Filings
1
Median premium
59%
First filing
Jan 7, 2020
Latest filing
Jan 7, 2020

Targets

CompanyScore before dealScore nowFilingsLatest
Foamix Pharmaceuticals Ltd.——1Jan 7, 2020

Deal filings

FiledCompanyFormPricePremium
Jan 7, 2020Foamix Pharmaceuticals Ltd.DEFM14A$0.5959.24%